FDA Approves Otezla®for the Treatment of Oral Ulcers in Behcet’s Disease
Celgene Corporation announced on July 19 that the U.S. Food and Drug Administration (FDA) has approved Otezla® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behcet’s disease. Otezla, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only…...
Updated: Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
Brief Summary: Primary Objective: To evaluate the efficacy of sarilumab in patients with giant cell arteritis (GCA) as assessed by the proportion of patients with sustained remission for sarilumab compared to placebo, in combination with a corticosteroid (CS) tapering course. Secondary Objective: To demonstrate the efficacy of sarilumab in patients…...
Rituximab Gains Expanded Approval in Pediatrics
The Food and Drug Administration has expanded the approval of Rituxan® injection (rituximab) to include the treatment of children ≥2 years of age who have granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), in combination with glucocorticoids. Rituximab is a CD20-directed cytolytic monoclonal antibody first approved in 1997 to treat…...
Podcast Series Offers Insights on What It’s Like to Live with Vasculitis
Although being diagnosed with vasculitis can feel scary at times, one thing that can help you manage the disease and come to terms with it is talking to other patients. VF Board Member Sara Baird Amodio, MSW, EdD, was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome) in…...
Kent Town, Australia, Neurologist Receives Honorable Mention in Vasculitis Foundation’s 2019 V-RED Award Program
The program has grown into a powerful campaign that raises awareness about early diagnosis. (Kent Town, Australia, September 2019) Andrew Lee, MBBS, MPH, FRACP, A/Prof, has received an honorable mention in the Vasculitis Foundation’s (VF’s) 2019 Recognizing Excellence in Diagnostics (V-RED) award program. Dr. Lee, a neurologist in Kent Town,…...
